Avac Event

HIV R4P

Cape Town International Convention Centre in Cape Town, South Africa

The HIV Research for Prevention (R4P) conference is the first global conference to cover all forms of biomedical HIV prevention, including AIDS vaccines, microbicides, PrEP, treatment as prevention and other approaches. 

The conference concluded on Friday, October 31 but session webcasts and conference reports are available below as are links to slides and the recording of AVAC’s post-R4P webinar—The State of the HIV Prevention Union: The Road from R4P.

AVAC’s Daily Snapshot 

Each day, AVAC offered up a selective, whirlwind tour through the day’s sessions—check them out below:

Webcasts

The conference has made all of the oral presentations, including the opening and closing sessions, available as webcasts. Download them here.

Blog and Social Media

WhatsUpHIV is a live blog set up to report developments from HIV R4P. Over 50 entries were published from advocates, community journalists and researchers.

Visit the social media archive of the conference on Twitter and Facebook via #HIVR4P.

Media Clips

Ken Mayer has a great summary of the conference in the Lancet.

Download a comprehensive 107-page document of media clippings.

The CBC has dispatches from the conference including news about RV144 and next steps, the growing responsibility of African countries in fighting HIV/AIDS and the advantages of a microbicide gel and vaginal ring for women in preventing HIV

Channel Africa interviewed Sharon Hillier, Jim Kublin and Mitchell Warren.

South Africa’s Mail & Guardian published a supplement on the R4P conference.

Conference Posters

All conference posters are available here. AVAC posters from R4P are available to download below.

Avac Event

What Will it Take to Achieve an AIDS-Free World?

This inaugural translational medicine conference: What Will it Take to Achieve an AIDS-Free World?, which will bring the audiences and editors of The Lancet and Cell together to bridge the gap between clinicians and researchers focused on understanding, managing, preventing and curing HIV/AIDS.

The ambition is to host a meeting every year that will address the most pressing topics in translational medicine. The 2013 inaugural conference will offer:

  • A combination of contributions from basic researchers, physicians, policy leaders and industry scientists working on HIV/AIDS
  • World-renowned speakers with a broad range of expertise across the interlocking fields of HIV research and clinical practice
  • Opportunities for knowledge exchange and synergy to accelerate progress in addressing the disease

The desire to reach out and connect across disciplines can be hampered by lack of a common language. At the conference the editors of Cell and The Lancet will curate sessions that are designed to capture the energy at the interface between basic researchers and physicians that we hope will start new conversations that will catalyze the development of new translational approaches and solutions.

 

Avac Event

Treatment as Prevention Perspectives in Europe: An update

Hosted jointly by NAM and AVAC, the last webinar for 2013 in our series addressed a range of topics in HIV prevention research, including the development of the EATG/NAM community consensus statement on treatment as prevention, a set of principles intended to guide policy on access to antiretroviral therapy for prevention purposes for people with HIV, to be launched in January.

To view the full Flash animation of the webinar, click here.

Avac Event

Risky Women: Disrupting simple notions of women’s HIV risk

The final webinar of the Fall series discussed what is known from social and behavioral science and community experience about the definitions and perceptions of HIV risk among women that are relevant to their potential PrEP use.

Avac Event

PrEP-ception: Sero-discordant couples using PrEP to reduce HIV transmission risk during pregnancy

The second in a series of webinars by the US Women and PrEP Working Group discussed the possibilities and challenges associated with serodiscordant couples using PrEP to help them achieve pregnancy safely.

Avac Event

AIDS Vaccine 2013

AIDS Vaccine 2013 took place from October 7–10 in Barcelona, Spain. AIDS Vaccine is the largest global scientific conference focused exclusively on AIDS vaccine research. Hosted annually by the Global HIV Vaccine Enterprise and local partners, AIDS Vaccine brings together the best and brightest scientific minds to exchange the latest research findings, explore new ideas, educate future leaders and engage a diverse community to help further research to develop a safe and effective HIV vaccine.

For the full program, click here . And, much of the conference is available via webcast here.

Avac Event

Ready, Set, PrEP: Update on current research and rollout of PrEP for women in the US

The US Women and PrEP Working Group held a webinar to discuss the latest in research and rollout of PrEP for women in the US. To learn more about the US Women and PrEP Working Group (and hear about upcoming webinars), visit www.prepwatch.org.

Avac Event

HIV Prevention Europe Webinars: Rectal microbicides

The seventh webinar in our series addressing a range of topics in HIV prevention research, hosted jointly by NAM and AVAC, will focus on rectal microbicides. The presentation was followed by a Q&A session.

Avac Event

US Conference on AIDS

Thousands of community leaders, front-line workers, policy makers, physicians and advocates from throughout the US met for the United States Conference on AIDS (USCA). What follows is a short list of biomedical HIV prevention research and implementation-related sessions and links to the Black Treatment Action Network/PxROAR Advocates’ Roadmap and full conference program. (The Black Treatment Action Network is a project of the Black AIDS Institute.)

The BTAN/PxROAR Advocates’ Roadmap highlights workshops, seminars and roundtables on a range of issues such as HIV prevention advocacy, access to treatment, linkage to care and the treatment cascade. Advocates who attend Roadmap sessions at the conference are eligible for prizes. Click here for more information.

Sessions of interest for biomedical HIV prevention advocates included:

Saturday, September 7

Sunday, September 8

Monday, September 9

Tuesday, September 10

Wednesday, September 11

Avac Event

New WHO guidelines on the use of ARVs for treating and preventing HIV

On June 30, the World Health Organization (WHO) released updated Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. AVAC, Global Network of People of Living with HIV (GNP+), the International HIV/AIDS Alliance (Alliance), and STOP AIDS NOW! (SAN!) held a webinar to discuss the guidelines and a new tool—Community Guide to Treatment as Prevention Programming.

The call included a brief overview of the guidelines by Gottfried Hirnschall, the Director of the Department of HIV/AIDS at WHO, as well as other resource people who were involved in the development of the guidelines and are engaged in translating these guidelines into practice.

In addition, Moono Nyambe from GNP+ discussed the “community” reactions toward the guidelines and described the collaborative effort led by GNP+, Alliance and SAN! to develop the Community Guide (to help communities understand the substance of the WHO guidelines and get involved in programming and implementation at country level).